[1]Zhang YD,Huang QW,Ma C,et al. Magnetic fluorescent molecularly imprinted nanoparticles for detection and separation of transferrin in human serum[J]. Talanta,2018,188:540-545.
[2]Chan KT,Choi MY,Lai KK,et al. Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma[J]. Oncol Rep,2014,31(3):1296-304.
[3]Tortorella S,Karagiannis TC. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy[J]. J Membr Biol,2014,247(4):291-307.
[4]Abouzeid AH,Patel NR,Sarisozen C,et al. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells[J]. Pharm Res,2014,31(8):1938-1945.
[5]Choudhury H,Pandey M,Chin PX,et al. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends[J]. Drug Deliv Transl Res,2018,8(5):1545-1563.
[6]Cui Y,Xu Q,Chow PK,et al. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment[J]. Biomaterials,2013,34(33):8511-8520.
[7]耿怀成,陈龙邦.抗体介导的抗肿瘤血管治疗[J] .医学研究生学报,2001,14(6):535-537.
[8]Hu Q,Wang Y,Xu L,et al. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy[J]. Int J Nanomedicine,2020,15:2751-2764.
[9]Wigner P,Zielinski K,Labieniec-Watala M,et al.Doxorubicin-transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells[J]. Sci Rep,2021,11 (1):4544.
[10]Du W,Fan Y,He B,et al. Correction to "Bionano Interactions of MCF-7 Breast Tumor Cells with a Transferrin Receptor Targeted Nanoparticle"[J]. Mol Pharm,2021,18 (5):2104.
[11]Zhu M,Sheng Z,Jia Y,et al. Correction to "Indocyanine Green-holo-Transferrin Nanoassemblies for Tumor-Targeted Dual-Modal Imaging and Photothermal Therapy of Glioma"[J]. ACS Appl Mater Interfaces,2021,13 (21):25574.
[12]Mirzaei H,Naseri G,Rezaee R,et al. Curcumin: A new candidate for melanoma therapy?[J] Int J Cancer,2016,139(8):1683-1695.
[13]Momtazi AA,Derosa G,Maffioli P,et al. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases[J]. Mol Diagn Ther,2016,20(4):335-345.
[14]Sahebkar A,Cicero AFG,Simental-Mendia LE,et al. Curcumin downregulates human tumor necrosis factor-alpha levels: A systematic review and meta-analysis ofrandomized controlled trials[J]. Pharmacol Res,2016,107:234-242.
[15]Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr,2014,33(3):406-414.
[16]Perrone D,Ardito F,Giannatempo G,et al. Biological and therapeutic activities,and anticancer properties of curcumin[J]. Exp Ther Med,2015,10(5):1615-1623.
[17]Mahmood K,Zia KM,Zuber M,et al. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review[J]. Int J Biol Macromol,2015,81:877-890.
[1]朱庆,曹燕丽,徐云燕,等.酸变性法构建转铁蛋白?姜黄素纳米粒子及其肿瘤靶向性[J].医学研究与战创伤救治(原医学研究生学报),2019,21(3):262.[doi:10.3969/j.issn.1672-271X.2019.03.009]
ZHU Qing,CAO Yan-li,XU Yun-yan,et al.Construction of transferrin curcumin nanoparticles by acid denaturation and its tumor targeting[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(2):262.[doi:10.3969/j.issn.1672-271X.2019.03.009]